A pesar de los indudables avances de la medicina, la realidad es que en torno al 40% de la población padecerá enfermedades crónicas, entre ellas degenerativas o autoinmunes, que no tienen cura. El creciente conocimiento científico pone de manifiesto la gran complejidad de los mecanismos de esas enfermedades. Intentar solucionarlas mediante los clásicos medicamentos, que…
DetailsGijón, Spain – 17 December 2020 – Gistem Research SL, a research driven company that is dedicated to the discovery and development of novel and innovative approaches derived from mesenchymal stem cells, has announced that it has been granted patent protection (Patent Number ZL 2014800100633) for their human Uterine Cervical Stem cell´s method and uses …
DetailsPonencia del Dr. Vizoso Jefe de la Unidad de Investigación de la Fundación Hospital de Jove y Director del Comité Científico de FICEMU: ”Crisis del coronavirus: Nuevos problemas que exigen nuevas soluciones”. Organizado por SINERGY ONLINE FORUMS .
Tuesday 29th, 2019. Gistem Research, a start-up focused on the development of innovative stem cell-derived therapies, will receive an investment of EUR 800.000 from the Caja Rural Bank. This financial support will facilitate the development of its dry eye programme. With the proceeds, Gistem will enter clinical testing, as well as secure a full series…
DetailsGijón (Spain) and Guimarães (Portugal) – October 2nd, 2019 Gistem Research SL has signed an agreement with the Portuguese CDMO Stemmatters SA that will cover the manufacturing of Gistem´s novel stem cell-derived therapy for the treatment of dry eye. According to the agreement, Stemmatters is responsible for the transfer process, scale-up, process validation and…
DetailsGistem Research secures European Patent Protection for hUCESCs. Gijón, Spain – 17 June 2019 – Gistem Research SL, a research driven company that is dedicated to the discovery and development of novel and innovative approaches derived from mesenchymal stem cells, has announced that it has been granted patent protection (Patent Number PCT/2014/053508) for their human Uterine Cervical Stem cell´s method…
Details
